These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 1728747

  • 1. Vaccination with gp160 in HIV.
    Oyaizu N, Chirmule N, Pahwa S.
    N Engl J Med; 1992 Jan 30; 326(5):347; author reply 348. PubMed ID: 1728747
    [No Abstract] [Full Text] [Related]

  • 2. Vaccination with gp160 in HIV.
    Stanberry LR, Bernstein DI, Myers MG.
    N Engl J Med; 1992 Jan 30; 326(5):347-8. PubMed ID: 1728748
    [No Abstract] [Full Text] [Related]

  • 3. Vaccination with gp160 in HIV.
    Seligman SJ.
    N Engl J Med; 1992 Jan 30; 326(5):347; author reply 348. PubMed ID: 1558566
    [No Abstract] [Full Text] [Related]

  • 4. Current progress in HIV vaccines.
    Westblom TU, Belshe RB, Gorse GJ.
    Mo Med; 1991 Nov 30; 88(11):762-5. PubMed ID: 1805131
    [No Abstract] [Full Text] [Related]

  • 5. AIDS vaccine boosts immunity in HIV patients.
    RN; 1991 Oct 30; 54(10):103. PubMed ID: 1925340
    [No Abstract] [Full Text] [Related]

  • 6. [AIDS--HIV envelope protein improves vaccination response].
    GURTLER L.
    Fortschr Med; 1991 Dec 10; 109(35):10-1. PubMed ID: 1774002
    [No Abstract] [Full Text] [Related]

  • 7. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
    Dis Markers; 1991 Dec 10; 9(1):51. PubMed ID: 1742945
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Positive response. Encouraging results in the search for an AIDS vaccine.
    Beardsley T.
    Sci Am; 1991 Aug 10; 265(2):26. PubMed ID: 1862329
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of a vaccinia-derived recombinant HIV-1 gp160 candidate vaccine and its immunogenicity in chimpanzees.
    Barrett N, Eder G, Dorner F.
    Biotechnol Ther; 1991 Aug 10; 2(1-2):91-106. PubMed ID: 1845126
    [Abstract] [Full Text] [Related]

  • 17. Gp160 of commercial HIV western blots is not gp160env. Should criteria for seropositivity be revised?
    Fenouillet E, Blanes N, Gluckman JC.
    AIDS; 1991 Jun 10; 5(6):770. PubMed ID: 1883550
    [No Abstract] [Full Text] [Related]

  • 18. Cellular immune response to HIV gp160 vaccine.
    Stricker RB, Goldberg B.
    J Acquir Immune Defic Syndr (1988); 1994 Sep 10; 7(9):989. PubMed ID: 7914236
    [No Abstract] [Full Text] [Related]

  • 19. Effect of nonprotective vaccination on antibody response to subsequent human immunodeficiency virus infection.
    Pincus SH, Messer KG, Hu SL.
    J Clin Invest; 1994 Jan 10; 93(1):140-6. PubMed ID: 8282780
    [Abstract] [Full Text] [Related]

  • 20. HIV-1 soluble antigens induced CD8+ cytotoxic T-cell responses in an immunized individual.
    Achour A, Moukrim Z, Picard O, Bizzini B, Burny A, Zagury D.
    Cell Mol Biol (Noisy-le-grand); 1995 May 10; 41(3):395-400. PubMed ID: 7580833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.